Marshall Wace’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-219,900
Closed -$12.7M 2772
2023
Q1
$12.7M Buy
219,900
+44,500
+25% +$3M 0.03% 625
2022
Q4
$12.7M Buy
175,400
+25,400
+17% +$1.82M 0.03% 689
2022
Q3
$9.12M Buy
+150,000
New +$9.58M 0.02% 958
2021
Q4
Sell
-900
Closed -$56K 4130
2021
Q3
$56K Hold
900
﹤0.01% 2932
2021
Q2
$54K Sell
900
-6,000
-87% -$380K ﹤0.01% 2572
2021
Q1
$419K Buy
+6,900
New +$381K ﹤0.01% 2012

Other funds holding MET

Marshall Wace's MET Position: Q1 2026 in Review

Marshall Wace sold out of MetLife (MET) in Q1 2026, closing a stake of 3,600 shares — an estimated $284K sold.

Marshall Wace first reported a position in MET in Q1 2015 and held it in 20 quarters. The position peaked at $80.7M in Q4 2021. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Marshall Wace reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
  • Marshall Wace sold 3,600 MetLife shares in Q1 2026, an estimated $284K.
  • Marshall Wace first reported a position in MetLife in Q1 2015 and held it in 20 quarters.
  • Marshall Wace's MetLife position peaked at $80.7M in Q4 2021.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.